Treatment of metastatic RCC was challenging in the past as chemotherapy and radiotherapy were not much effective and cytokine therapy with interleukin-2 or interferon alfa had limited efficacy and considerable toxic effects3,4,6,7. This evidence concerns the gene IL2 and renal cell carcinoma.